Amato MP - Search Results

1

Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis.

Roos I, Leray E, Casey R, Horakova D, Havrdova E, Izquierdo G, Madueño SE, Patti F, Edan G, Debouverie M, Pelletier J, Ozakbas S, Amato MP, Clavelou P, Grammond P, Boz C, Buzzard K, Skibina O, Ciron J, Gerlach O, Grand'Maison F, Lechner-Scott J, Malpas C, Butzkueven H, Vukusic S, Kalincik T; MSBase and OFSEP Study Groups. Roos I, et al. Among authors: amato mp. Neurology. 2021 Aug 31;97(9):e869-e880. doi: 10.1212/WNL.0000000000012354. Epub 2021 Jun 30. Neurology. 2021. PMID: 34193589

2

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.

De Stefano N, Bartolozzi ML, Nacmias B, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, Amato MP. De Stefano N, et al. Among authors: amato mp. Arch Neurol. 2004 Apr;61(4):536-40. doi: 10.1001/archneur.61.4.536. Arch Neurol. 2004. PMID: 15096402

3

Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents.

Amato MP. Amato MP. Expert Opin Pharmacother. 2004 Oct;5(10):2115-26. doi: 10.1517/14656566.5.10.2115. Expert Opin Pharmacother. 2004. PMID: 15461547 Review.

4

European validation of a standardized clinical description of multiple sclerosis.

Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system (EVALUED) Study Group. Amato MP, et al. J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346

5

Donepezil for memory impairment in multiple sclerosis.

Amato MP. Amato MP. Lancet Neurol. 2005 Feb;4(2):72-3. doi: 10.1016/S1474-4422(05)00972-5. Lancet Neurol. 2005. PMID: 15664536 No abstract available.

6

Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort.

Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, Siracusa G, Masini M, Sorbi S, Trojano M. Amato MP, et al. J Neurol. 2006 Aug;253(8):1054-9. doi: 10.1007/s00415-006-0161-8. Epub 2006 Apr 11. J Neurol. 2006. PMID: 16609810

7

Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities.

Gagliardo A, Galli F, Grippo A, Amantini A, Martinelli C, Amato MP, Borsini W. Gagliardo A, et al. Among authors: amato mp. J Neurol. 2007 Feb;254(2):220-7. doi: 10.1007/s00415-006-0334-5. Epub 2007 Feb 17. J Neurol. 2007. PMID: 17308868

8

Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.

Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N. Amato MP, et al. Arch Neurol. 2007 Aug;64(8):1157-61. doi: 10.1001/archneur.64.8.1157. Arch Neurol. 2007. PMID: 17698706

9

Improving compliance with interferon-beta therapy in patients with multiple sclerosis.

Portaccio E, Amato MP. Portaccio E, et al. Among authors: amato mp. CNS Drugs. 2009;23(6):453-62. doi: 10.2165/00023210-200923060-00001. CNS Drugs. 2009. PMID: 19480465

10

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters